These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 39386736)

  • 41. Machine Learning-Based Characterization and Identification of Tertiary Lymphoid Structures Using Spatial Transcriptomics Data.
    Li S; Wang Z; Huang HD; Lee TY
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy.
    Bao X; Lin X; Xie M; Yao J; Song J; Ma X; Zhang X; Zhang Y; Liu Y; Han W; Liang Y; Hu H; Xu L; Xue X
    Front Immunol; 2024; 15():1413067. PubMed ID: 39026670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer.
    An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD
    Front Immunol; 2022; 13():1049884. PubMed ID: 36420257
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma.
    Tanaka T; Masuda A; Inoue J; Hamada T; Ikegawa T; Toyama H; Sofue K; Shiomi H; Sakai A; Kobayashi T; Tanaka S; Nakano R; Yamada Y; Ashina S; Tsujimae M; Yamakawa K; Abe S; Gonda M; Masuda S; Inomata N; Uemura H; Kohashi S; Nagao K; Kanzawa M; Itoh T; Ueda Y; Fukumoto T; Kodama Y
    J Gastroenterol; 2023 Mar; 58(3):277-291. PubMed ID: 36705749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma.
    Ling Y; Zhong J; Weng Z; Lin G; Liu C; Pan C; Yang H; Wei X; Xie X; Wei X; Zhang H; Wang G; Fu J; Wen J
    Clin Transl Med; 2022 Oct; 12(10):e1074. PubMed ID: 36245289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer.
    He M; He Q; Cai X; Liu J; Deng H; Li F; Zhong R; Lu Y; Peng H; Wu X; Chen Z; Lao S; Li C; Li J; He J; Liang W
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction.
    Wang Z; Niu D
    Sci Rep; 2024 Jun; 14(1):13555. PubMed ID: 38867070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
    Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
    Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma.
    Shu DH; Ho WJ; Kagohara LT; Girgis A; Shin SM; Danilova L; Lee JW; Sidiropoulos DN; Mitchell S; Munjal K; Howe K; Bendinelli KJ; Kartalia E; Qi H; Mo G; Montagne J; Leatherman JM; Lopez-Vidal TY; Zhu Q; Huff AL; Yuan X; Hernandez A; Coyne EM; Zaidi N; Zabransky DJ; Engle LL; Ogurtsova A; Baretti M; Laheru D; Durham JN; Wang H; Sunshine JC; Johnston RJ; Deutsch JS; Taube JM; Anders RA; Jaffee EM; Fertig EJ; Yarchoan M
    Nat Immunol; 2024 Nov; 25(11):2110-2123. PubMed ID: 39455893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer.
    Sofopoulos M; Fortis SP; Vaxevanis CK; Sotiriadou NN; Arnogiannaki N; Ardavanis A; Vlachodimitropoulos D; Perez SA; Baxevanis CN
    Cancer Immunol Immunother; 2019 Nov; 68(11):1733-1745. PubMed ID: 31598757
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy.
    Zou X; Guan C; Gao J; Shi W; Cui Y; Zhong X
    Front Immunol; 2023; 14():1222719. PubMed ID: 37529035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spatial genomics reveals a high number and specific location of B cells in the pancreatic ductal adenocarcinoma microenvironment of long-term survivors.
    Aziz HM; Saida L; de Koning W; Stubbs AP; Li Y; Sideras K; Palacios E; Feliu J; Mendiola M; van Eijck CHJ; Mustafa DAM
    Front Immunol; 2022; 13():995715. PubMed ID: 36685537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Mature Tertiary Lymphoid Structure with a Ki-67-Positive Proliferating Germinal Center Is Associated with a Good Prognosis and High Intratumoral Immune Cell Infiltration in Advanced Colorectal Cancer.
    Mori N; Dorjkhorloo G; Shiraishi T; Erkhem-Ochir B; Okami H; Yamaguchi A; Shioi I; Komine C; Endo M; Seki T; Hosoi N; Nakazawa N; Shibasaki Y; Okada T; Osone K; Sano A; Sakai M; Sohda M; Yokobori T; Shirabe K; Saeki H
    Cancers (Basel); 2024 Jul; 16(15):. PubMed ID: 39123412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer.
    de Chaisemartin L; Goc J; Damotte D; Validire P; Magdeleinat P; Alifano M; Cremer I; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
    Cancer Res; 2011 Oct; 71(20):6391-9. PubMed ID: 21900403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.
    George B; Kudryashova O; Kravets A; Thalji S; Malarkannan S; Kurzrock R; Chernyavskaya E; Gusakova M; Kravchenko D; Tychinin D; Savin E; Alekseeva L; Butusova A; Bagaev A; Shin N; Brown JH; Sethi I; Wang D; Taylor B; McFall T; Kamgar M; Hall WA; Erickson B; Christians KK; Evans DB; Tsai S
    Gastroenterology; 2024 May; 166(5):859-871.e3. PubMed ID: 38280684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The enrichment of the gut microbiota Lachnoclostridium is associated with the presence of intratumoral tertiary lymphoid structures in hepatocellular carcinoma.
    Zhao R; Li J; Chen B; Zhao J; Hu L; Huang K; Chen Q; Yao J; Lin G; Bao L; Lu M; Wang Y; Chen G; Wu F
    Front Immunol; 2023; 14():1289753. PubMed ID: 38116013
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
    Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
    Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy.
    Langouo Fontsa M; Padonou F; Willard-Gallo K
    Expert Rev Clin Immunol; 2024 Aug; 20(8):839-847. PubMed ID: 39007892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer.
    Sun X; Liu W; Sun L; Mo H; Feng Y; Wu X; Li C; Chen C; Li J; Xin Y; Zhang Z; Wang C; Zhang B; Yue D
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 37011953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence.
    Zhang S; Yuan L; Danilova L; Mo G; Zhu Q; Deshpande A; Bell ATF; Elisseeff J; Popel AS; Anders RA; Jaffee EM; Yarchoan M; Fertig EJ; Kagohara LT
    bioRxiv; 2023 Jan; ():. PubMed ID: 36712023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.